Few consumer staples companies can claim what this global household products leader has built over nearly two centuries: a brand portfolio selling essential personal care, home care, and baby care products in roughly 180 countries, a forward dividend yield of 2.95%, a beta of just 0.39 against a peer group average of 0.49, and a 3-year dividend CAGR of 5% that comfortably outpaces the consumer products industry average of 3%. Those are not coincidental figures. They reflect a business engineered around repeat-purchase, non-discretionary categories, where pricing power compounds quietly over decades. The company’s most recent fiscal quarter confirmed that the broad-based organic sales recovery management had been signaling was real, with all 10 product categories growing simultaneously for the first time in recent memory, and all 7 geographic regions holding or growing.
That momentum, however, comes with near-term cost headwinds that are equally real. Energy expenses tied to Middle Eastern conflict dynamics and Section 301 tariffs on Chinese-origin goods are expected to weigh more heavily on the fiscal fourth quarter than the third, and management itself guided for somewhat softer organic growth in the coming period. These are legitimate risks for a company with a global supply chain of this complexity, and investors should weigh them alongside the fundamentals. The business has sustained 40 consecutive quarters of organic sales growth through recessions, a pandemic, and an inflationary cycle, which says something important about how these products behave across economic conditions. The dividend was raised again this year, the 70th consecutive annual increase, and management committed to approximately $15 billion in total cash returns to shareholders for the full fiscal year.
This stock has been reaffirmed in the Best Consumer Staple Dividend Stocks Portfolio on the strength of its exceptional dividend safety profile, its low-volatility characteristics, and its proven ability to generate consistent shareholder returns across market cycles. For a quality-focused portfolio that prizes durability and income reliability over speculative growth, this reaffirmation reflects a considered judgment that the company’s fundamentals continue to justify a place among the best dividend-paying stocks available to long-term investors.
